≡ Menu

VITEK® 2 Gram Negative Susceptibility Card With Piperacillin Tazobactambio Recall Issued By bioMérieux Over E. Coli & K. Pneumoniae Antimicrobial Susceptibility Testing

bioMérieux Recalls VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin Tazobactam Over Reports of Potential Incorrect Testing Results.

A medical and laboratory equipment product correction recall has been issued by bioMérieux, Inc. (“bioMérieux”) recalling VITEK® 2 Gram Negative Susceptibility Cards containing the antibiotic Piperacillin Tazobactam (TZP2) used in clinical laboratories to perform antimicrobial susceptibility testing reportedly because an internal investigation confirmed reports that testing may incorrectly report E. coli and K. pneumoniae susceptible isolates as resistant to Piperacillin Tazobactam (TZP2) and E. coli isolates resistant to Piperacillin Tazobactam (TZP2) may be incorrectly identified as susceptible, according to a Food & Drug Administration (“FDA”) medical and laboratory equipment product correction recall news report.

For more information on the VITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin Tazobactambio product correction recall, contact bioMérieux at 1-800-682-2666, option 3.

If You Have Thoughts On The bioMérieux ITEK® 2 Gram Negative Susceptibility Cards Containing Piperacillin Tazobactambio Product Correction Recall, Share Your Medical & Laboratory Equipment Recall Comments Below.

{ 0 comments… add one }

Leave a Comment